Renal injury can sometimes be induced by drugs. Some examples of renal damage-inducing drugs include some widespread treatments, such as ß-Lactam antibiotics, bisphosphonates, non-steroidal anti-inflammatory drugs, diuretics, aminoglycoside antibiotics, antineoplastic agents and radiocontrast agents.
Since 2008, both the FDA and the EMEA indicated that additional tests may be necessary to assess new drug safety and prevent from renal toxicity. Though these recommendations are voluntary, many pharmaceutical companies have started gathering data on nephrotoxicity biomarkers.
